Home / Roles / Titles / Principal Scientist / CA / FY2023
Principal Scientist H-1B roles in CA, FY2023
Exact-title LCA role declarations for Principal Scientist in CA during FY2023. Rows include employer, SOC, worksite, status, decision date, offered wage, prevailing wage, and source evidence. Showing 20 returned rows using keyset pagination.
Summary
This view lists 20 H-1B LCA role records.
Offered wages among the returned rows range from $105,290 to $400,000.
Employers in the returned rows include Bristol-Myers Squibb Company, Genentech, Inc., Alamar Biosciences, Inc., Impossible Foods Inc., InnoPeak Technology, Inc..
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Role | Employer | SOC | Status / visa | Decision | Worksite | Offered wage | Prevailing wage | Source |
|---|---|---|---|---|---|---|---|---|
| Principal Scientist I-200-23198-193322 | Bristol-Myers Squibb Company | 19-1021.00 Biochemists and Biophysicists | Certified / H-1B FY2023 | 2023-07-24 2023-08-01 to 2026-07-31 | Redwood City, CA, 94063 | $145,805 year | $109,741 | sr_dol_oflc_lca_2023_q4_row_103378 |
| Principal Scientist I-200-23173-137890 | Genentech, Inc. | 19-1029.01 Bioinformatics Scientists | Certified / H-1B FY2023 | 2023-06-29 2023-12-21 to 2026-12-20 | South San Francisco, CA, 94080 | $142,400 to $275,664 year | $107,702 | sr_dol_oflc_lca_2023_q3_row_003471 |
| Principal Scientist I-200-23162-098486 | Alamar Biosciences, Inc. | 19-2031.00 Chemists | Certified / H-1B FY2023 | 2023-06-16 2023-06-23 to 2026-06-22 | Fremont, CA, 94538 | $210,000 year | $119,517 | sr_dol_oflc_lca_2023_q3_row_029244 |
| Principal Scientist I-200-21071-141077 | Impossible Foods Inc. | 19-1012.00 Food Scientists and Technologists | Certified - Withdrawn / H-1B FY2023 | 2023-05-18 2021-04-19 to 2024-04-18 | Redwood City, CA, 94063 | $105,290 to $190,000 year | $105,290 | sr_dol_oflc_lca_2023_q3_row_088181 |
| Principal Scientist I-200-23121-981774 | Genentech, Inc. | 19-1042.00 Medical Scientists, Except Epidemiologists | Certified / H-1B FY2023 | 2023-05-08 2023-10-01 to 2026-09-30 | South San Francisco, CA, 94080 | $165,888 to $215,904 year | $111,509 | sr_dol_oflc_lca_2023_q3_row_113963 |
| Principal Scientist I-200-23116-967978 | InnoPeak Technology, Inc. | 19-2012.00 Physicists | Certified / H-1B FY2023 | 2023-05-03 2023-10-01 to 2026-09-30 | Palo Alto, CA, 94303 | $201,656 to $400,000 year | $201,656 | sr_dol_oflc_lca_2023_q3_row_122560 |
| Principal Scientist I-200-23109-947097 | Roche Molecular Systems, Inc. | 19-1021.00 Biochemists and Biophysicists | Certified / H-1B FY2023 | 2023-04-26 2023-10-14 to 2026-10-13 | Pleasanton, CA, 94588 | $111,072 to $197,700 year | $111,072 | sr_dol_oflc_lca_2023_q3_row_139076 |
| Principal Scientist I-200-23102-926533 | Sastra Cell Therapy | 19-1029.00 Biological Scientists, All Other | Certified / H-1B FY2023 | 2023-04-19 2023-04-17 to 2026-04-16 | Camarillo, CA, 93012-6793 | $170,000 year | $103,085 | sr_dol_oflc_lca_2023_q3_row_152489 |
| Principal Scientist I-200-23102-925905 | Nobell Foods, Inc. | 19-1012.00 Food Scientists and Technologists | Certified / H-1B FY2023 | 2023-04-19 2023-05-01 to 2026-04-30 | South San Francisco, CA, 94080 | $175,000 year | $119,766 | sr_dol_oflc_lca_2023_q3_row_153045 |
| Principal Scientist I-203-22272-501310 | Teva Pharmaceuticals USA, Inc. | 19-1021.00 Biochemists and Biophysicists | Certified - Withdrawn / E-3 Australian FY2023 | 2023-04-12 2022-10-10 to 2024-10-09 | Redwood City, CA, 94063 | $145,000 to $175,000 year | $111,072 | sr_dol_oflc_lca_2023_q3_row_165457 |
| Principal Scientist I-200-23082-871460 | Zoetis, Inc. | 19-1021.00 Biochemists and Biophysicists | Certified / H-1B FY2023 | 2023-03-30 2023-08-15 to 2026-08-14 | Lafayette, CA, 94549 | $124,384 year | $111,072 | sr_dol_oflc_lca_2023_q2_row_003710 |
| Principal Scientist I-200-23061-817809 | MyoKardia, Inc. | 19-1021.00 Biochemists and Biophysicists | Certified / H-1B FY2023 | 2023-03-09 2023-08-26 to 2026-08-25 | Brisbane, CA, 94005 | $151,410 year | $129,355 | sr_dol_oflc_lca_2023_q2_row_041125 |
| Principal Scientist I-200-23019-713279 | Medtronic, Inc. | 17-2031.00 Bioengineers and Biomedical Engineers | Certified / H-1B FY2023 | 2023-01-26 2023-02-20 to 2026-02-19 | Northridge, CA, 91325 | $116,688 to $144,000 year | $116,688 | sr_dol_oflc_lca_2023_q2_row_108275 |
| Principal Scientist I-203-23012-698005 | 10x Genomics, Inc. | 19-1029.02 Molecular and Cellular Biologists | Certified / E-3 Australian FY2023 | 2023-01-19 2023-07-01 to 2025-06-30 | Pleasanton, CA, 94588 | $200,000 to $235,000 year | $129,002 | sr_dol_oflc_lca_2023_q2_row_116223 |
| Principal Scientist I-200-22343-632143 | Novartis Institutes for BioMedical Research, Inc. | 19-1042.00 Medical Scientists, Except Epidemiologists | Certified / H-1B FY2023 | 2022-12-16 2023-06-08 to 2026-06-07 | San Diego, CA, 92121 | $115,190 year | $115,190 | sr_dol_oflc_lca_2023_q1_row_013729 |
| Principal Scientist I-200-22343-632143 | Novartis Institutes for BioMedical Research, Inc. | 19-1042.00 Medical Scientists, Except Epidemiologists | Certified / H-1B FY2023 | 2022-12-16 2023-06-08 to 2026-06-07 | San Diego, CA, 92121 | $115,190 year | $115,190 | sr_dol_oflc_lca_2023_q2_row_147538 |
| Principal Scientist I-200-22305-561393 | Genpharm International LLC | 19-1021.00 Biochemists and Biophysicists | Certified / H-1B FY2023 | 2022-11-08 2023-01-27 to 2026-01-26 | Redwood City, CA, 94063 | $148,756 year | $129,355 | sr_dol_oflc_lca_2023_q1_row_050627 |
| Principal Scientist I-200-22305-561393 | Genpharm International LLC | 19-1021.00 Biochemists and Biophysicists | Certified / H-1B FY2023 | 2022-11-08 2023-01-27 to 2026-01-26 | Redwood City, CA, 94063 | $148,756 year | $129,355 | sr_dol_oflc_lca_2023_q2_row_189640 |
| Principal Scientist I-203-22272-501310 | Teva Pharmaceuticals USA, Inc. | 19-1021.00 Biochemists and Biophysicists | Certified / E-3 Australian FY2023 | 2022-10-06 2022-10-10 to 2024-10-09 | Redwood City, CA, 94063 | $145,000 to $175,000 year | $111,072 | sr_dol_oflc_lca_2023_q1_row_083232 |
| Principal Scientist I-203-22272-501310 | Teva Pharmaceuticals USA, Inc. | 19-1021.00 Biochemists and Biophysicists | Certified / E-3 Australian FY2023 | 2022-10-06 2022-10-10 to 2024-10-09 | Redwood City, CA, 94063 | $145,000 to $175,000 year | $111,072 | sr_dol_oflc_lca_2023_q2_row_226589 |
End of returned pageReset
Frequently asked questions
- What are the offered H-1B wages for Principal Scientist H-1B roles in CA, FY2023?
- Offered wages among the returned Principal Scientist H-1B roles in CA, FY2023 rows range from $105,290 to $400,000 in DOL LCA filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/roles?limit=50&title=principal+scientist&title_match=exact&state=CA&fiscal_year=2023JSON